Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry ...

The Pennant Group (Nasdaq: PNTG) is not stopping its plans for growth following the announcement that the company agreed to acquire home health centers ...

The sales are contingent on the closure of UnitedHealth’s acquisition of Amedisys, which has been held up after the ...

We've reviewed over 50 of the best office chairs - from budget options to executive builds - but for our money, these are the top choices you can get right now. We've tested each for real-world ...

In a report released today, Matt Larew from William Blair maintained a Hold rating on Amedisys (AMED – Research Report). The company’s shares closed yesterday at $93.63. Discover outperforming ...

More than 3,300 hospitals and 114,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in ...

Amedisys (AMED) reported $594.78 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 4.1%. EPS of $1.25 for the same period compares to $1.03 a year ago.

Read more from The Wall Street Journal. Q1 earnings: Baton Rouge-based Amedisys reported that its net service revenue increased by $23.4 million in the first quarter of 2025 to $594.8 million ...

(2) Adjusted EBITDA is defined as net income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain items as ...

(RTTNews) - Amedisys (AMED) announced earnings for its first quarter that increased from the same period last year and beat the Street estimates. The company's bottom line totaled $61.01 million ...

Amedisys shares have climbed 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $93.56, an increase of almost 3% in the last 12 months.